Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
March 7, 2023
FDA Issues Draft Guidance on “External Controls” in Clinical Trials to Support Safety and Efficacy of a Drug
February 2, 2023
It’s Not Just for Dietary Supplements Anymore: FTC Revises and Expands Guidance for Health Claims
January 10, 2023
MDD Certificates Remain Valid: European Commission Proposes Longer Transition Periods for MDR Compliance
February 13, 2023
Restructuring partner Geoffrey King joins the firm’s Corporate, Finance and Investments practice group in Chicago